We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Nobel Prize Awarded for Fundamental Discoveries in the Developmental Capacity of Mature Cells

By LabMedica International staff writers
Posted on 15 Oct 2012
The 2012 Nobel Prize for Physiology or Medicine jointly awarded to scientists John B. More...
Gurdon and Shinya Yamanaka recognizes the fundamental nature of their discoveries about the capacity of mature, specialized cells to be reprogrammed back into immature, pluripotent stem-like cells. The prize also reflects recognition of important progress being made in medical research based on these groundbreaking discoveries.

The process of developing from an immature into a specialized cell was previously considered to be unidirectional and irreversible. It was thought that during maturation the cell undergoes certain changes that include loss of the capacity to return to a pluripotent stage. John B. Gurdon, long-time professor of cell biology at the University of Cambridge (Cambridge, UK) and currently at the Gurdon Institute (Cambridge, UK), challenged this dogma that the specialized cell is irreversibly committed. In 1962, Prof. Gurdon published a landmark study in the Journal of Embryology and Experimental Morphology titled “The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles.” In this classic experiment, he replaced the immature nucleus of a frog egg cell with the nucleus from a mature intestinal cell. This modified egg cell developed into a normal tadpole, showing that the DNA of the mature cell still contained all the genetic information required for the development of all the cells of a fully functional frog. This conclusion was eventually confirmed and generalized to other organisms, including mammals, by independent studies performed by other researchers.

Prof. Gurdon’s experiment involved mechanical removal of intact nuclei from cells and introduction of a nucleus from a specialized cell into a de-nucleated nonspecialized cell. Over 40 years later, Shinya Yamanaka, currently professor at Kyoto University (Kyoto, Japan) and affiliated with the Gladstone Institutes (San Francisco, CA, USA), discovered that it was also possible to reprogram fully intact mature cells to become pluripotent cells by the introduction of only a few specific genes in a specific combination, discovered by testing various combinations from a set of previously identified candidate genes. This groundbreaking study from Prof. Yamanaka’s laboratory was published in 2006 in the journal Cell, titled “Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.” These induced pluripotent stem cells (iPSC) have already constituted another breakthrough in developmental biology. And by reprogramming also human cells, scientists have created new opportunities to study human disease mechanisms and develop methods for medical therapy and diagnosis.

Related Links:

Nobel Foundation
Gurdon Institute
Kyoto University



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
Rapid Test Reader
DIA5000
New
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Microbiology

view channel
Image: The groundbreaking salmonella antimicrobial resistance prediction platform has demonstrated 95% accuracy (Photo courtesy of Yujie You et al., DOI: 10.1016/j.eng.2025.01.013)

New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance

Antimicrobial-resistant Salmonella strains are a growing public health concern due to the overuse of antimicrobials and the rise of genetic mutations. Accurate prediction of resistance is crucial for effective... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more

Technology

view channel
Image: The newly designed ExoPatch successfully distinguished melanoma from healthy skin in mice (Photo courtesy of Jeremy Little/Michigan Engineering)

Microneedle Skin Patch Detects Melanoma Without Biopsy or Blood Draw

Melanoma, the most aggressive form of skin cancer, currently requires patients, especially those with fair skin and moles, to undergo regular doctor visits and biopsies every six months to determine if... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.